Pipeline 2

PlatformProgramDomain 1Domain 2IndicationsCombination AgentsDiscoveryPreclinicalPhase 1Phase 2Phase 3
Clinical-Stage Pipeline
ARCSL-172154SIRPαCD40LOvarian Cancer(1)Liposomal Doxorubicin
ARCSL-172154AML and HR-MDS(2)Azacitidine +/- Venetoclax
ARCSL-279252PD-1OX40LSolid Tumors & Lymphoma
Preclinical-Stage Pipeline
ARCMultipleMultipleMultipleOncology
GADLENMultipleγδ TCRTumor AntigenOncology